Toward Improved Methodology to Measure the Uptake of Mammography in Populations Using Insurance Claims: A Case Study From Delaware, USA
JCO Clinical Cancer Informatics · 2026-10 · 10 (4)
DOI: 10.1200/cci-26-00065 ↗Abstract
Purpose Quantifying the uptake of screening mammography at a population level is challenged by suboptimal surveillance data. Insurance claims represent a potentially useful data source; however, claims data can be limited by misclassification. Using a quantitative bias analysis framework, we demonstrate an approach for dealing with imperfect accuracy in an insurance claims database. Methods Insurance claims were obtained at the census tract level for screening mammography for the State of Delaware for 2019 and 2022. A measurement model was used to relate the observed uptake of mammography to the true uptake via two approaches: (1) the total number of medical claims and (2) the proportion of government-funded health insurance. Probabilistic Monte Carlo methods yielded a simulation distribution of screening mammograms accounting for misclassification and the associated uncertainty in misclassification parameters. Results During the year 2022 and based on the observed measure, the statewide average uptake was 172 mammograms per 1,000 women age 40 and above. This figure increased to a median of 176 mammograms per 1,000 women (95% simulation interval: 173 to 179) using the first adjustment approach and 322 mammograms per 1,000 women (95% simulation interval: 309 to 336) using the second adjustment approach. Conclusion When working with administrative data sets for measuring the uptake of screening mammography in a population, researchers and health care administrators should account for potential underreporting.
EUVIMED